Page last updated: 2024-12-08

thymidine 5'-diphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thymidine 5'-diphosphate: see also record for thymidine 3',5'-diphosphate, RN 2863-04-9 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dTDP : A thymidine phosphate having a diphosphate group at the 5'-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID164628
CHEMBL ID259724
CHEBI ID18075
SCHEMBL ID154111
MeSH IDM0090333

Synonyms (38)

Synonym
CHEBI:18075 ,
thymidine-5'- diphosphate
thymidine 5'-diphosphate
thymidine 5'-pyrophosphate
thymidine 5'-(trihydrogen diphosphate)
2'-deoxyribosylthymine 5'-(trihydrogen diphosphate)
thymidine 5'-(trihydrogen pyrophosphate) (8ci)
5-tdp
thymidine pyrophosphate (6ci)
5'-tdp
thymidine 5'-pyrophosphate (7ci)
thymidine 5-(trihydrogen pyrophosphate)
tdp (nucleotide)
mono(trihydrogen diphosphate)
thymidine 5-(trihydrogen diphosphate)
2,4(1h,3h)-pyrimidinedione, 1-[2-deoxy-5-o-[hydroxy(phosphonooxy)phosphinyl]-beta-d-erythro-pentofuranosyl]-5-methyl-
thymidine diphosphate
tyd ,
thymidine, mono(trihydrogen diphosphate) (ester)
deoxy-tdp
thymidine-5'-diphosphate
C00363
491-97-4
dtdp
deoxythymidine 5'-diphosphate
thymidine 5'-(trihydrogen diphosphate) (9ci)
DB03103
CHEMBL259724
[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate
qq3k1p45df ,
unii-qq3k1p45df
SCHEMBL154111
{[hydroxy({[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}phosphonic acid
Q2186340
((2r,3r,5r)-5-(5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl)-3-oxidanyl-oxolan-2-yl)methyl phosphono hydrogen phosphate
2-chloro-1 3-dimethylimidazolinium
DTXSID801027011
((2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
thymidine phosphate
pyrimidine 2'-deoxyribonucleoside 5'-diphosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (15)

PathwayProteinsCompounds
Pyrimidine Metabolism2353
beta-Ureidopropionase Deficiency2353
UMP Synthase Deficiency (Orotic Aciduria)2353
Dihydropyrimidinase Deficiency2353
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)2353
Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis917
Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis 2917
Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis 3820
Pyrimidine Deoxyribonucleosides Salvage815
Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )4549
ATP + dTMP = ADP + dTDP ( Pyrimidine Nucleotides and Nucleosides metabolism )14
ATP + dTDP = ADP + dTTP ( Pyrimidine Nucleotides and Nucleosides metabolism )74
Pyrimidine synthesis and deprivation pathway (COVID-19 Disease Maps)1329
purine and pyrimidine metabolism032
Biochemical pathways: part I0466
Pyrimidine metabolism038

Protein Targets (2)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nucleoside diphosphate kinase AHomo sapiens (human)Activity1.30001.30001.30001.3000AID325381
Nucleoside diphosphate kinase BHomo sapiens (human)Activity1.40001.40001.40001.4000AID325384
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
GTP biosynthetic processNucleoside diphosphate kinase AHomo sapiens (human)
UTP biosynthetic processNucleoside diphosphate kinase AHomo sapiens (human)
CTP biosynthetic processNucleoside diphosphate kinase AHomo sapiens (human)
DNA metabolic processNucleoside diphosphate kinase AHomo sapiens (human)
endocytosisNucleoside diphosphate kinase AHomo sapiens (human)
nervous system developmentNucleoside diphosphate kinase AHomo sapiens (human)
lactationNucleoside diphosphate kinase AHomo sapiens (human)
negative regulation of cell population proliferationNucleoside diphosphate kinase AHomo sapiens (human)
cell differentiationNucleoside diphosphate kinase AHomo sapiens (human)
regulation of apoptotic processNucleoside diphosphate kinase AHomo sapiens (human)
positive regulation of DNA bindingNucleoside diphosphate kinase AHomo sapiens (human)
positive regulation of epithelial cell proliferationNucleoside diphosphate kinase AHomo sapiens (human)
GTP biosynthetic processNucleoside diphosphate kinase BHomo sapiens (human)
UTP biosynthetic processNucleoside diphosphate kinase BHomo sapiens (human)
CTP biosynthetic processNucleoside diphosphate kinase BHomo sapiens (human)
cell adhesionNucleoside diphosphate kinase BHomo sapiens (human)
integrin-mediated signaling pathwayNucleoside diphosphate kinase BHomo sapiens (human)
nucleoside triphosphate biosynthetic processNucleoside diphosphate kinase BHomo sapiens (human)
negative regulation of apoptotic processNucleoside diphosphate kinase BHomo sapiens (human)
positive regulation of keratinocyte differentiationNucleoside diphosphate kinase BHomo sapiens (human)
regulation of epidermis developmentNucleoside diphosphate kinase BHomo sapiens (human)
positive regulation of DNA-templated transcriptionNucleoside diphosphate kinase BHomo sapiens (human)
positive regulation of transcription by RNA polymerase IINucleoside diphosphate kinase BHomo sapiens (human)
positive regulation of epithelial cell proliferationNucleoside diphosphate kinase BHomo sapiens (human)
regulation of apoptotic processNucleoside diphosphate kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
magnesium ion bindingNucleoside diphosphate kinase AHomo sapiens (human)
RNA bindingNucleoside diphosphate kinase AHomo sapiens (human)
DNA nuclease activityNucleoside diphosphate kinase AHomo sapiens (human)
nucleoside diphosphate kinase activityNucleoside diphosphate kinase AHomo sapiens (human)
protein bindingNucleoside diphosphate kinase AHomo sapiens (human)
ATP bindingNucleoside diphosphate kinase AHomo sapiens (human)
GTP bindingNucleoside diphosphate kinase AHomo sapiens (human)
3'-5' exonuclease activityNucleoside diphosphate kinase AHomo sapiens (human)
identical protein bindingNucleoside diphosphate kinase AHomo sapiens (human)
ribosomal small subunit bindingNucleoside diphosphate kinase AHomo sapiens (human)
DNA bindingNucleoside diphosphate kinase BHomo sapiens (human)
transcription coactivator activityNucleoside diphosphate kinase BHomo sapiens (human)
nucleoside diphosphate kinase activityNucleoside diphosphate kinase BHomo sapiens (human)
protein histidine kinase activityNucleoside diphosphate kinase BHomo sapiens (human)
protein bindingNucleoside diphosphate kinase BHomo sapiens (human)
ATP bindingNucleoside diphosphate kinase BHomo sapiens (human)
GDP bindingNucleoside diphosphate kinase BHomo sapiens (human)
metal ion bindingNucleoside diphosphate kinase BHomo sapiens (human)
G-quadruplex DNA bindingNucleoside diphosphate kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
nucleusNucleoside diphosphate kinase AHomo sapiens (human)
cytoplasmNucleoside diphosphate kinase AHomo sapiens (human)
early endosomeNucleoside diphosphate kinase AHomo sapiens (human)
cytosolNucleoside diphosphate kinase AHomo sapiens (human)
membraneNucleoside diphosphate kinase AHomo sapiens (human)
ruffle membraneNucleoside diphosphate kinase AHomo sapiens (human)
extracellular exosomeNucleoside diphosphate kinase AHomo sapiens (human)
focal adhesionNucleoside diphosphate kinase BHomo sapiens (human)
ruffleNucleoside diphosphate kinase BHomo sapiens (human)
extracellular regionNucleoside diphosphate kinase BHomo sapiens (human)
nucleusNucleoside diphosphate kinase BHomo sapiens (human)
cytoplasmNucleoside diphosphate kinase BHomo sapiens (human)
cytosolNucleoside diphosphate kinase BHomo sapiens (human)
lamellipodiumNucleoside diphosphate kinase BHomo sapiens (human)
secretory granule lumenNucleoside diphosphate kinase BHomo sapiens (human)
perinuclear region of cytoplasmNucleoside diphosphate kinase BHomo sapiens (human)
extracellular exosomeNucleoside diphosphate kinase BHomo sapiens (human)
cell peripheryNucleoside diphosphate kinase BHomo sapiens (human)
ficolin-1-rich granule lumenNucleoside diphosphate kinase BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID325382Activity of human recombinant nm23H1 assessed as conversion of 1 umol of ADP to ATP per min2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325384Activity of human recombinant nm23H22007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325378Activity of 3-phosphoglycerate kinase from crude human CEM cell extract2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325379Activity of 3-phosphoglycerate kinase from crude human CEM cell extract assessed as conversion of 1 umol of ADP to ATP per min2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325370Activity of nucleoside diphosphate kinase from crude human CEM cell extract assessed as conversion of 1 umol of ADP to ATP per min2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325381Activity of human recombinant nm23H12007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325387Activity of human recombinant 3-phosphoglycerate kinase2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325372Activity of creatine kinase from crude human CEM cell extract2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325374Activity of creatine kinase from crude human CEM cell extract assessed as phosphorylation efficiency relative to D4TDP2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325389Activity of human recombinant 3-phosphoglycerate kinase assessed as phosphorylation efficiency relative to 4-ethynyl D4TDP2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325388Activity of human recombinant 3-phosphoglycerate kinase assessed as conversion of 1 umol of ADP to ATP per min2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325376Activity of pyruvate kinase from crude human CEM cell extract assessed as conversion of 1 umol of ADP to ATP per min2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325386Activity of human recombinant nm23H2 assessed as phosphorylation efficiency relative to 4-ethynyl D4TDP2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325369Activity of nucleoside diphosphate kinase from crude human CEM cell extract2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325383Activity of human recombinant nm23H1 assessed as phosphorylation efficiency relative to 4-ethynyl D4TDP2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325375Activity of pyruvate kinase from crude human CEM cell extract2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325380Activity of 3-phosphoglycerate kinase from crude human CEM cell extract assessed as phosphorylation efficiency relative to 4-ethynyl D4TDP2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325373Activity of creatine kinase from crude human CEM cell extract assessed as conversion of 1 umol of ADP to ATP per min2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325371Activity of nucleoside diphosphate kinase from crude human CEM cell extract assessed as phosphorylation efficiency relative to D4TDP2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325377Activity of pyruvate kinase from crude human CEM cell extract assessed as phosphorylation efficiency relative to 4-ethynyl D4TDP2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
AID325385Activity of human recombinant nm23H2 assessed as conversion of 1 umol of ADP to ATP per min2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (34.78)18.7374
1990's3 (13.04)18.2507
2000's9 (39.13)29.6817
2010's3 (13.04)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.32 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]